George Medicines PTY Limited
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, George Medicines PTY Limited sits in the upper half of US sponsors by registered trial count (#4,887 of 15,751 sponsors by registered trial count).
George Medicines PTY Limited: 2 sponsored US clinical trials, none currently recruiting.
George Medicines PTY Limited sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 1 trials.
Mid-pack sponsor footprint
George Medicines PTY Limited is in the upper half of sponsors by trial count (#4,887 of 15,751 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Therapeutic Areas
How the George Medicines PTY Limited archive is shaped
2 indexed studies, none listed as recruiting (0% open); 2 completed (100%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Hypertension (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.